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Key messages
What is already known about this subject?
 ► It is not known how utilisation of non- invasive im-
aging tests and exercise treadmill tests (ETT) have 
changed in the UK in view of changing recommen-
dations for their use.
What does this study add?
 ► Utilisation of non- invasive imaging tests rose sub-
stantially (81%) between 2011 and 2017, while 
use of ETT has reduced only modestly (8%). There 
was no change in audit figures for invasive angiog-
raphy, percutanoues coronary intervention (PCI) or 
coronary artery bypass grafting (CABG) in the same 
period.
How might this impact on clinical practice?
 ► This study provides an insight into current non- 
invasive testing utilisation but also identifies areas 
for improvements in provision and appropriate use 
of non- invasive imaging tests.
ABSTRACT
Objective To document UK rates of exercise treadmill 
testing, functional stress testing and CT coronary 
angiography (CTCA). Specific aims were to determine 
how rates have changed in the context of changing 
guideline recommendations within the UK and to identify 
regional inequalities in the utilisation of testing modalities. 
Secondary objectives were to compare these trends with 
national data on revascularisation.
Methods 159 acute National Health Service trusts were 
served Freedom of Information (FOI) requests to provide 
total numbers of CTCA and functional imaging tests for 
each financial year from 2011–2012 to 2016–2017.
Results The FOI requests yielded data from 88% of 
Trusts, increasing from 81.9% in 2011–2012% to 92.1% 
in 2016–2017. Exercise treadmill tests (ETTs) were 
performed by over 97% of Trusts. ETT was the most 
commonly performed diagnostic test in the UK across the 
study period despite declining by 8.4%. Utilisation of non- 
invasive stress imaging tests increased by 80.9% during 
the same period. Myocardial perfusion scintigraphy and 
stress echocardiography increased by 25.8% and 73.9%, 
respectively. The 268% increase in CTCA scans was yet 
greater. Trends in test utilisation during the study period 
showed important regional differences between devolved 
nations. Comparably, only small changes in rates of 
invasive coronary angiography and revascularisation have 
been reported during the study period.
Conclusion Non- invasive imaging in UK Trusts has 
increased substantially since 2010 with only a small 
decline in use of the ETT and minimal changes in rates of 
invasive coronary angiography and revascularisation in the 
same time period.
IntROduCtIOn
The last 10 years have seen major shifts in UK 
guideline recommendations for non- invasive 
cardiac testing of patients with undiagnosed 
chest pain. Historically exercise treadmill 
testing (ETT) was recommended as a diag-
nostic test in patients with suspected coronary 
artery disease in the UK.1 In 2010 the National 
Institute of Care Excellence (NICE) changed 
this by recommending that the (ETT) 
should no longer be used for this purpose 
due to poor diagnostic accuracy and instead 
recommended use of non- invasive imaging 
testing for more accurate diagnosis of coro-
nary artery disease. A further 6 years later in 
2016 the guideline was further nuanced with 
CT coronary angiography (CTCA) becoming 
the favoured investigation for all patients 
with new atypical or typical chest pain2 3 and 
with perfusion and stress imaging preferred 
for patients with a known diagnosis of coro-
nary artery disease or unsuitable for CTCA. 
European guidelines for management of 
chronic coronary syndromes largely mirror 
these recommendations with an emphasis on 
use of non- invasive testing prior to revascular-
isation.4
While recommendations for ETT in 
patients with undiagnosed chest pain are 
now diminished these tests continue to have 
an important role for patients with other 
cardiac disorders.1 Equally since the 2010 
NICE guideline the scope for use of non- 
invasive imaging tests has widened beyond 
just stable coronary artery disease. Cardiac 
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Figure 1 Methods flowchart. FOI, Freedom of Information; NHS, National Health Service.
CT are important tools in assessing aortic stenosis, masses 
or congenital heart diseases. Stress echocardiography can 
be a helpful discriminator in ‘low- flow’ aortic stenosis. 
Cardiac MRI or myocardial perfusion scintigraphy (MPS) 
are used to guide revascularisation decisions using both 
perfusion and viability assessments.
With expanding indications for these tests, it is not 
known how their utilisation has changed within the UK 
in recent years. It is equally unclear how this in turn has 
impacted rates of invasive coronary angiography (ICA) 
and revascularisation. These questions are important not 
only for bench marking purposes but also for identifying 
efficiency of resources utilisation at a time of increasing 
constraints.5 In the present study we have addressed this 
knowledge gap by documenting for the first- time rates of 
non- invasive testing across UK cardiac centres. Specific 
aims were to determine how rates of testing have changed 
since 2010 and to identify regional inequalities in the util-
isation of testing modalities.
MetHOds
159 acute National Health Service (NHS) trusts and 
health boards providing adult cardiology services in 
England, Scotland, Wales and Northern Ireland were 
identified from each nations NHS website ( www. nhs. 
uk, https://www. scot. nhs. uk, http:// online. hscni. 
net, https://www. wales. nhs. uk). Each trust or health 
board was asked to provide information under the UK’s 
Freedom of Information (FOI) act 1998. Under the FOI 
act all public bodies must respond, if feasible within 20 
working days, to all requests for information that do not 
meet exclusions from the act. Each trust was sent five FOI 
requests via either email or an online request system, 
requesting that they provide the total numbers of non- 
invasive cardiac tests, both anatomical (CTCA) and func-
tional (ETT, stress perfusion cardiac MRI, myocardial 
stress perfusion and stress echocardiography) for each 
financial year from 2011–2012 to 2016–2017. No infor-
mation was requested regarding indication for the tests 
performed due to exclusions of the FOI act precluding 
this. An individual information request was made for 
each cardiac investigation and all requests were made 
within the period of 1 August 2018 to 31 December 
2018. Trusts not responding within 20 working days were 
chased for response via email up to three times before 
data were presumed to be missing (figure 1). Clarifi-
cation or rechecking of data was requested from the 
Trusts using SNOMED codes if incorrect or anomalous 
data was suspected (ie, data including non- stress cardiac 
MRI, inconsistency in numbers reported year to year or 
number of tests reported well above expected levels). 
The exact FOI requests made for each test can be found 
in online supplementary file 1. National rates of ICA and 
revascularisation were obtained from the British Cardio-
vascular Interventional Society and the Society for Cardi-
othoracic Surgery registries.6 7
This is a descriptive study and no formal statistical anal-
ysis has been performed.
Results are displayed as both total number of tests and 
tests per 100 000 of population per year in the UK. Tests 
are also represented as mean tests per NHS trust per year 
to account for unreported data from NHS trusts. Data for 
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Table 1 Total number and percentages of UK National Health Service trusts that responded to Freedom of Information 
requests performing individual tests between 2011–2012 and 2016–2017
Test 2011–2012 2012–2013 2013–2014 2014–2015 2015–2016 2016–2017
CTCA 77 (56.6%) 84 (59.2%) 100 (66.7%) 106 (70.2%) 111 (73.5%) 116 (74.4%)
ETT 122 (97.6%) 129 (97.0%) 132 (97.8%) 135 (97.8%) 138 (97.9%) 141 (97.9%)
SE 73 (60.3%) 85 (65.4%) 98 (73.1%) 102 (73.4%) 109 (76.8%) 115 (80.4%)
CMR 27 (19.6%) 35 (24.8%) 39 (27.3%) 40 (27.6%) 44 (30.1%) 46 (31.5%)
MPS 79 (60.3%) 82 (61.7%) 88 (63.3%) 89 (62.7%) 92 (64.3%) 91 (63.6%)
CMR, cardiac stress/perfusion MRI; CTCA, CT coronary angiography; ETT, exercise treadmill testing; MPS, myocardial perfusion 
scintigraphy; SE, stress echocardiography.
Table 2 Test utilisation in UK National Health Service trusts between 2011–2012 and 2016–2017
Test 2011–2012 2012–2013 2013–2014 2014–2015 2015–2016 2016–2017
CTCA 141.7 192.9 240.9 280.8 322.1 454.7
ETT 1088.2 1007.6 1003.1 964.6 907.7 865.6
SE 292.0 322.0 349.7 374.1 402.4 429.8
CMR 44.3 56.4 72.8 82.0 94.9 107.1
MPS 530.3 573.7 636.8 628.3 613.8 611.4
Data are the total numbers of tests performed each year.
CMR, cardiac stress/perfusion MRI; CTCA, CT coronary angiography; ETT, exercise treadmill testing; MPS, myocardial perfusion 
scintigraphy; SE, stress echocardiography.
each devolved nation are represented as total numbers 
and also test per 100 000 of the population. Office of 
National Statistics population data for the UK and 
devolved nations was used for each successive year from 
2011 to 2016 (see online supplementary file 1). Change 
in test utilisation is represented as a delta from start to 
end of the period studied.
Regional heat maps were created using GoogleFusion 
Maps and Keyhole Markup Language files for each NHS 
sustainability and transformation partnership (STP) or 
health boards in devolved nations. Tests were normalised 
to the NHS published populations for each STP foot-
print in England (2016) and reported populations for 
each health board in Wales (2009), Scotland (2014) and 
Northern Ireland (2016). This is represented as tests per 
100 000 of these populations.
Results
data completeness
A total of 795 FOI requests were made between 1 August 
2018 and 30 October 2018. For all diagnostic tests the 
requests yielded data from 88% of UK NHS Trusts, the 
yield increasing from 81.9% in 2011–2012% to 92.1% in 
2016–2017 (see online supplementary file 1).
exercise treadmill test (ett)
ETTs were performed by over 97% of reporting Trusts 
during the study period (table 1). In 2011–2012 the 
ETT was the most commonly performed diagnostic test 
when 136 030 (215.3 per 100 000) were performed across 
the UK (table 2). Thereafter total numbers declined 
gradually, as non- invasive imaging tests came to be used 
more commonly (see figures 2 and 3 and). By 2016–2017 
the total number of ETTs performed in the UK had 
fallen by 8.4% to 124 647 (189.9 tests per 100 000, 11.8% 
decrease), with non- invasive imaging now predominantly 
used. The data, normalised to those Trusts that supplied 
ETT information (table 3), showed a similar pattern 
with a 20.5% decrease in the mean number of ETTs per 
reporting Trust.
non-invasive imaging tests
Numbers of non- invasive imaging tests increased steeply 
during the study period, rising by 80.9% from 130 180 in 
2011–2012 (206 tests per 100 000) to 235 447 in 2016–
2017 (358.7 tests per 100 000). By 2012–2013, numbers 
had exceeded numbers of ETTs (table 1).
Functional imaging
MPS was offered by 60.3% of reporting Trusts in 2011–
2012 with little change during the study period (table 1). 
It was the most commonly utilised functional imaging 
test with the total number of scans increasing by 25.8% 
during the study period, from 69 463 in 2011–2012 (109.9 
tests per 100 000) to a peak of 89 224 in 2014–2015 (138.1 
tests per 100 000), declining slightly the next 2 years.
Stress echo imaging was offered by 60.3% of reporting 
Trusts in 2011–2012, increasing to 80.4% in 2016–2017 
(table 1). The number of studies in 2011–2012 was 35 338 
(55.9 tests per 100 000) but utilisation increased by 73.9% 
thereafter, peaking at 61 458 in 2016–2017 (93.6 tests per 
100 000), only 30% lower than the number of MPS scans.
Open Heart
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Figure 2 Total number of cardiac tests performed in 
the UK. CMR, cardiac stress/perfusion MRI; CTCA, CT 
coronary angiography; ETT, exercise treadmill testing; 
MPS, myocardial perfusion scintigraphy; SE, stress 
echocardiography.
Figure 3 Cardiac Tests compared with Angiography and 
Revascularisation rate.
Cardiac stress MRI was offered by only 19.6% of 
reporting Trusts in 2011–2012, increasing to 31.5% in 
2016–2017 (table 1). The number of scans was consis-
tently lower compared with other imaging tests but 
increased by 155.9% during the study period from 6109 
(9.7 tests per 100 000) in 2011–2012 to 15 634 (23.8 tests 
per 100 000) in 2016–2017. The data normalised to those 
Trusts that supplied functional imaging information 
(table 3) confirmed MPS as the most widely used test per 
Trust and showed similar patterns of increasing imaging 
activity, most marked for cardiac stress MRI.
CT coronary angiography
CTCAs were offered by 56.0% of reporting Trusts in 
2011–2012, increasing to 74.4% in 2016–2017 (table 1). 
The number of CTCAs totalled 19 270 in 2011–2012 (30.5 
tests per 100 000) but increased by 268% during the 
study period, peaking at 70 928 in 2016–2017 (108 tests 
per 100 000). The data normalised to those Trusts that 
supplied information (table 3) showed a similar pattern 
of increasing CTCA activity during the study period.
Regional inequalities in non-invasive test utilisation
ETT utilisation between 2011–2012 and 2016–2017 
declined in English and Welsh Trusts by 15.8%, and 
13.5%, respectively, but in Scottish Trusts ETT utilisa-
tion increased by 14.1% and in Northern Ireland Trusts, 
where ETT per 100 000 population far exceeded rates 
elsewhere in the UK, its utilisation increased by 25.0% 
(see figure 3 and online supplementary file 1). Non- 
invasive imaging tests during the same period increased 
in English, Welsh and Northern Ireland Trusts by 85.1%, 
115.7% and 50.7% but in Scottish Trusts the increase was 
only 3.9% (see figure 3 and online supplementary file 1), 
marking Scotland as the UK state performing the fewest 
non- invasive imaging tests.
Utilisation of CTCA showed the greatest increase in 
English and Welsh Trusts (281.4% and 290.0%) but in 
Scottish and Northern Ireland Trusts increases in CTCA 
utilisation were more modest (68.9% and 45.6%) and 
were dwarfed by increases in stress echo utilisation 
(172.9% and 291.1%). Stress cardiac stress/perfusion 
MRI (CMR) utilisation in all regions was relatively low 
but showed large increases during the study period (see 
figure 4, figure 5 and online supplementary file 1).
Invasive angiography and revascularisation
National registry data from the British Cardiovascular 
Interventional Society showed a 7.7% increase in diag-
nostic ICA during the study period, numbers increasing 
from 144 506 in 2011 to 155 777 in 2016 (figure 2). A 
similar 6.4% increase in percutaneous coronary interven-
tion procedures for stable angina occurred during the 
same period, numbers increasing from 30 526 in 2011 to 
32 475 in 2016. Elective isolated coronary bypass opera-
tions recorded in the Society for Cardiothoracic Surgery 
registry declined by 17.5% during the study period, from 
10 671 in 2011 to 8804 in 2015 (most recent available 
data).
dIsCussIOn
This study reports the utilisation of non- invasive func-
tional and anatomical tests by hospital Trusts across 
the UK. Temporal trends during a 6- year period from 
2011–2012 to 2016–2017 show that utilisation of all non- 
invasive imaging tests has increased substantially while 
utilisation of exercise treadmill tests has tended to slowly 
decline. Trends in test utilisation during the study period 
showed important regional differences, with Scottish and 
Northern Irish Trusts reporting little change in utilisa-
tion of non- invasive imaging tests.
In the 2010 NICE guideline ETT was no longer recom-
mended to be used to diagnose or exclude stable angina. 
This recommendation, based largely on the inferior 
diagnostic performance of the ETT compared with non- 
invasive imaging tests,8 has been validated by investiga-
tors who have reported that its diagnostic and prognostic 
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Table 3 Mean test utilisation in UK National Health Service trusts between 2011–2012 and 2016–2017
Cardiac test 2011–2012 2012–2013 2013–2014 2014–2015 2015–2016 2016–2017
CTCA—total 19 270 27 388 36 132 42 405 48 643 70 928
  Per 100 000 population 30.5 43.0 56.4 65.6 74.7 108.0
SE—total 35 338 41 861 46 859 51 999 57 146 61 458
  Per 100 000 population 55.9 65.7 73.1 80.5 87.8 93.6
CMR—total 6109 7948 10 408 11 885 13 857 15 634
  Per 100 000 population 9.7 12.5 16.2 18.4 21.3 23.8
MPS—total 69 463 76 301 88 514 89 224 87 776 87 427
  Per 100 000 population 109.9 119.8 138.1 138.1 134.8 133.2
ETT—total 136 030 134 012 135 420 133 116 127 986 124 647
  Per 100 000 population 215.3 210.4 211.2 206.1 196.6 189.9
All non- invasive imaging—total 130 180 153 498 181 913 195 513 207 422 235 447
  Per 100 000 population 206.0 241.0 283.8 302.7 318.6 358.7
Data are the mean number of tests performed each year by trusts that responded to the Freedom of Information requests.
CMR, cardiac stress/perfusion MRI; CTCA, CT coronary angiography; ETT, exercise treadmill testing; MPS, myocardial perfusion 
scintigraphy; SE, stress echocardiography.
value in patients with suspected angina is limited.9 10 In 
patients with established coronary artery disease, the ETT 
competes with a range of clinical factors for prognostic 
assessment and has either not been considered11 12 or 
has failed inclusion13 in the development of risk models. 
This study does not identify indications for non- invasive 
testing and as such the authors are cautious of drawing 
firm conclusions on the utilisation of ETT. Certainly, the 
changes in the 2010 NICE guidelines do not appear to 
have led to a significant drop in ETT use. Multiple factors 
are likely responsible for the continuing popularity of the 
ETT including its low cost, wide availability and status as a 
test that has been part of cardiological practice for more 
than 70 years. The superior diagnostic performance and 
cost- effectiveness of non- invasive imaging tests are well 
established14 and persistently high level of utilisation of 
ETTs may provide cause for concern if indeed they are 
being used for assessment of coronary artery disease. This 
is reflected in the many patients attending chest pain 
clinics who have a normal ETT but then go on to expe-
rience coronary events during follow- up.15 Notably trusts 
with the highest ETT.
The modest decline in the utilisation of ETTs by UK 
hospital Trusts during the study period was accompa-
nied by a sharp increase in the utilisation of non- invasive 
imaging tests. By 2012–2013 numbers of non- invasive 
imaging tests had exceeded numbers of ETTs and the gap 
in utilisation continued to increase thereafter with MPS 
the most commonly employed modality. Utilisation of all 
other non- invasive imaging tests also increased, particu-
larly CTCA, presumably reflecting its introduction as a 
clinical tool in NICE 2010 guideline recommendation for 
low risk patients, which has now been extended in the 
2016 update.2 3 However, only 74% of UK Trusts reported 
utilisation of CTCA in 2016–2017, validating concerns 
about the implementation of NICE recommendations.16 17
Regional inequalities in resources appear to remain a 
challenge with Scotland and Northern Ireland showing 
only modest increases in CTCA utilisation during the 
study period despite performing as many if not more 
scans proportional to population in 2011–2012 compared 
with England and Wales. By contrast England and Wales 
have expanded CTCA services more vigorously, by 302% 
and 290%, respectively, particularly in South of England 
and North Wales. However, Wales still lags behind other 
UK nations in its overall utilisation of CTCA.
The while the increase in utilisation of CTCA is likely 
to be related in part to NICE 2010 guidelines during 
the study period it is unclear, however, what effect this 
guideline has had on the use of functional imaging 
during the study period. The use of functional imaging 
often expands beyond use in chest pain clinics and not 
infrequently in patients with established coronary artery 
disease, previously revascularised patients or even acute 
coronary syndromes. What has driven increasing use 
of these functional tests is not evident from this study. 
The data does show that, within the functional imaging 
modalities, use of stress echocardiography and CMR 
stress perfusion is increasing, while use of MPS remains 
high but has stalled somewhat in growth. This is reflected 
in growing number of centres reporting use stress echo 
and CMR stress compared with a steady state of centres 
offering MPS.
This study also gives scale and proportion to utilisation 
of both anatomical (CTCA) and functional imaging in 
the UK. In 2016–2017, 30% of all non- invasive tests were 
CTCA with 70% being functional imaging. This balance 
has shifted from the beginning of the study when CTCA 
contributed just 15% of all non- invasive tests. Certainly, 
the high use of functional imaging across UK Trusts 
during the study period is consistent with the US expe-
rience,18–20 where concerns have been expressed about 
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Figure 4 Heat maps demonstrating changes in regional 
variation in exercise treadmill testing and non- invasive 
imaging test utilisation in the UK.
Figure 5 Heat maps demonstrating changes in regional 
variation in non- invasive imaging test utilisation in the 
UK. CMR, cardiac stress/perfusion MRI; CTCA, CT 
coronary angiography; ETT, exercise treadmill testing; 
MPS, myocardial perfusion scintigraphy; SE, stress 
echocardiography.
inappropriate indications and low diagnostic yield in 
terms of angiographic coronary artery disease.21–23 
Importantly there is no evidence that high use of func-
tional testing in US centres has driven improvements 
in outcomes.24 25 Conversely the SCOTHEART trial26 
has recently provided some evidence that anatomical 
imaging may improve prognosis, although in comparison 
to ETT testing.
The increase in diagnostic testing that has occurred 
during the study period has been accompanied with only 
small changes in numbers of ICA and PCI procedures 
across the UK. This is a surprising response to the addi-
tional 105 267 non- invasive tests and in particular >50 000 
additional CTCAs being performed per year that might 
be expected to have reduced the need for down- stream 
invasive investigation. Equally conversion rates of ICA to 
PCI have remained static at around 40% with no apparent 
improvement in the diagnostic yield of obstructive coro-
nary disease. There may be multiple explanations for this 
trend that cannot be described within this dataset alone. 
Two key drivers though are likely to be responsible for 
this.
First, the individual weakness of each non- invasive 
test may belie the answer to the static conversion rates 
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of ICA to PCI. Sensitivities and specificities of each non- 
invasive tests vary with CTCA having high specificity but 
reduced specificity for obstructive CAD, while functional 
imaging often has good specificity but lacks sensitivity for 
detecting CAD. This often leads clinicians with a choice 
of either ordering further tests or referring on for ICA 
as a final diagnostic test, even if this does not lead to 
revascularisation. Similar trends have been observed in 
the USA where increasing rates of invasive management 
have been recorded due to inappropriate or inaccu-
rate testing.21 The 2010 NICE guideline also included 
the recommendation of ICA for all patients with a risk 
score >61% which may have contributed to greater utility 
of ICA despite the score overestimating risk of CAD.2 27
Second, increased availability of testing demonstrated 
by this data does not mean these tests are being utilised 
appropriately as per guideline recommendations. In 
fact, the persistently high use of ETT even in 2016–2017 
should be seen as a strong indicator that clinicians are 
quite happy to deviate from guidelines. It could there-
fore be assumed that the same is being done with regards 
non- invasive imaging and ICA. No national audit data-
base exists linking non- invasive cardiac testing with down-
stream management. As such appropriateness of testing 
is unknown and cost analysis difficult to achieve. This 
study underlines the importance of prospective national 
auditing of non- invasive testing in order to achieve the 
cost savings predicted by NICE.3
Although the data reported in this study are novel and 
nationally relevant three important limitations that need 
to be acknowledged. First, although the response rate to 
FOI requests was high it was incomplete with the data 
yield increasing from 81.9% in 2011–2012% to 92.1% in 
2016–2017. The numbers of tests performed across the 
UK will therefore have been underestimated with some 
distortion of regional distribution although conclusions 
about the increasing use of anatomical and functional 
testing are unaffected. Second, data obtained from 
the FOI requests is dependent in part on the methods 
Trusts use in its collection. Most Trusts use coded data 
for recording diagnostic test utilisation but some extract 
numbers directly from cardiology or radiology depart-
ment records. However, it is reassuring that FOI utilisa-
tion data for CTCA are very similar to previous 2015–2016 
estimates using a different methodology and local vali-
dation at the authors centre appears accurate.17 Third, 
the indications or origin of requests for testing were not 
available for analysis and data from tests is not linked to 
the British Cardiovascular Intervention Society (BCIS) or 
the Society for Cardiothoracic Surgery (SCST) registries. 
As such this limits the conclusions that can be drawn on 
current practice.
This study has documented for the first time the utilisa-
tion of non- invasive testing modalities in Trusts across the 
UK. Numbers of non- invasive imaging tests have increased 
substantially with only a small decline in ETTs. The steep 
increase in utilisation of CTCA may reflect increasing 
guideline recommendations. Action is now required to 
reduce regional inequalities and determine appropriate-
ness of cardiac testing in order to take advantage of the 
diagnostic value and the financial savings predicted by 
NICE.3 The extent to which the increasing rate of imaging 
in the UK is clinically appropriate requires further review.
Contributors AA, RG and GT collected and analysed the data. AA drafted 
the manuscript. AW, KR, DJ provided critical analysis and helped re- draft the 
manuscript. AT edited the final version of the manuscript.
Funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not- for- profit sectors.
Map disclaimer The depiction of boundaries on the map(s) in this article do not 
imply the expression of any opinion whatsoever on the part of BMJ (or any member 
of its group) concerning the legal status of any country, territory, jurisdiction or 
area or of its authorities. The map(s) are provided without any warranty of any kind, 
either express or implied.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
data availability statement Data are available upon reasonable request.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCId id
Alex Asher http:// orcid. org/ 0000- 0003- 2110- 3001
RefeRences
 1 Recommendation for Clinical Exercise Tolerance Testing. Clinical 
guidance by consensus. Society for cardiological science and 
technology and British cardiovascular Society. Available: https://
www. scst. org. uk/ pages/ page_ box_ contents. asp? pageid= 808
 2 Chest pain of recent onset: assessment and diagnosis. Clinical 
guideline [CG95], 2010. Available: https://www. nice. org. uk/ 
Guidance/ CG95
 3 Chest pain of recent onset: assessment and diagnosis. Clinical 
guideline [CG95], 2016. Available: https://www. nice. org. uk/ guidance/ 
cg95
 4 Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the 
diagnosis and management of chronic coronary syndromes. Eur 
Heart J 2019;100.
 5 Walker S, Asaria M, Manca A, et al. Long- Term healthcare use and 
costs in patients with stable coronary artery disease: a population- 
based cohort using linked health records (caliber). Eur Heart J Qual 
Care Clin Outcomes 2016;2:125–40.
 6 BCIS. Audit Results 1991 to present - BCIS. [online], 2019. Available: 
https://www. bcis. org. uk/ resources/ audit- results/ [Accessed 30 May 
2019].
 7  Bluebook. scts. org. SCTS Blue Book Online - Cardiac Surgery 
Audit Data. [online], 2019. Available: http://www. bluebook. scts. org 
[Accessed 30 May 2019].
 8 Timmis A, Roobottom CA. National Institute for health and care 
excellence updates the stable chest pain guideline with radical 
changes to the diagnostic paradigm. Heart 2017;103:982–6.
 9 Genders TSS, Steyerberg EW, Hunink MGM, et al. Prediction model 
to estimate presence of coronary artery disease: retrospective 
pooled analysis of existing cohorts. BMJ 2012;344:e3485.
 10 Sekhri N, Feder GS, Junghans C, et al. Incremental prognostic 
value of the exercise electrocardiogram in the initial assessment of 
patients with suspected angina: cohort study. BMJ 2008;337:a2240.
 11 Clayton TC, Lubsen J, Pocock SJ, et al. Risk score for predicting 
death, myocardial infarction, and stroke in patients with stable 
angina, based on a large randomised trial cohort of patients. BMJ 
2005;331.
 12 Rapsomaniki E, Shah A, Perel P, et al. Prognostic models for stable 
coronary artery disease based on electronic health record cohort of 
102 023 patients. Eur Heart J 2014;35:844–52.
Open Heart
8 Asher A, et al. Open Heart 2019;6:e001186. doi:10.1136/openhrt-2019-001186
 13 Daly CA, De Stavola B, Sendon JLL, et al. Predicting prognosis in 
stable angina—results from the Euro heart survey of stable angina: 
prospective observational study. BMJ 2006;332:262–7.
 14 van Waardhuizen CN, Khanji MY, Genders TSS, et al. Comparative 
cost- effectiveness of non- invasive imaging tests in patients 
presenting with chronic stable chest pain with suspected coronary 
artery disease: a systematic review. Eur Heart J Qual Care Clin 
Outcomes 2016;2:245–60.
 15 Sekhri N, Feder GS, Junghans C, et al. How effective are rapid 
access chest pain clinics? prognosis of incident angina and 
non- cardiac chest pain in 8762 consecutive patients. Heart 
2007;93:458–63.
 16 Dreisbach JG, Nicol ED, Roobottom CA, et al. Challenges in 
delivering computed tomography coronary angiography as the first- 
line test for stable chest pain. Heart 2018;104:921–7.
 17 British Society of Cardiovascular Imaging. The challenge of national 
CT coronary angiography (CTCA) provision in response to NICE 
CG95 update, 2016. Available: www. bsci. org. uk/ images/ Documents/ 
2016_ BSCI_ BSCCT_ response_ to_ NICE_ CG95. pdf
 18 Ladapo JA, Blecker S, Douglas PS. Physician decision making 
and trends in the use of cardiac stress testing in the United States: 
an analysis of repeated cross- sectional data. Ann Intern Med 
2014;161:482–90.
 19 Ladapo JA, Blecker S, O'Donnell M, et al. Appropriate use of cardiac 
stress testing with imaging: a systematic review and meta- analysis. 
PLoS One 2016;11:e0161153.
 20 Ladapo JA, Blecker S, Douglas PS. Appropriateness of cardiac 
stress test use among primary care physicians and cardiologists in 
the United States. Int J Cardiol 2016;203:584–6.
 21 Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective 
coronary angiography. N Engl J Med 2010;362:886–95.
 22 Rozanski A, Gransar H, Hayes SW, et al. Temporal trends in the 
frequency of inducible myocardial ischemia during cardiac stress 
testing: 1991 to 2009. J Am Coll Cardiol 2013;61:1054–65.
 23 Duvall WL, Rai M, Ahlberg AW, et al. A multi- center assessment of 
the temporal trends in myocardial perfusion imaging. J Nucl Cardiol 
2015;22:539–51.
 24 Shah BR, McCoy LA, Federspiel JJ, et al. Use of stress testing 
and diagnostic catheterization after coronary stenting: association 
of site- level patterns with patient characteristics and outcomes in 
247,052 Medicare beneficiaries. J Am Coll Cardiol 2013;62:439–46.
 25 Safavi KC, Li S- X, Dharmarajan K, et al. Hospital variation in 
the use of noninvasive cardiac imaging and its association with 
downstream testing, interventions, and outcomes. JAMA Intern Med 
2014;174:546–53.
 26 Newby DE, Adamson PD, Berry C, et al. Coronary CT angiography 
and 5- year risk of myocardial infarction. N Engl J Med 
2018;379:924–33.
 27 Patel MR, Dai D, Hernandez AF, et al. Prevalence and predictors 
of nonobstructive coronary artery disease identified with coronary 
angiography in contemporary clinical practice. Am Heart J 
2014;167:846–52.
